SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085256-16-000033
Filing Date
2016-11-03
Accepted
2016-11-02 18:16:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 lgnd_2016rs13ga3.htm SC 13G/A 41052
  Complete submission text file 0001085256-16-000033.txt   42539
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43329 | Film No.: 161969316
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BUSH STREET SUITE 900 SAN FRANCISCO CA 94104
Business Address ONE BUSH STREET SUITE 900 SAN FRANCISCO CA 94104 4155912700
RS INVESTMENT MANAGEMENT CO LLC (Filed by) CIK: 0001085256 (see all company filings)

IRS No.: 943321067
Type: SC 13G/A